Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2023 Apr 13:14:1196523.
doi: 10.3389/fendo.2023.1196523. eCollection 2023.

Editorial: Steroid hormone receptors and cell cycle in breast cancer

Victoria T Fabris  1 , Laura Spring  2 , Luisa A Helguero  3
Affiliations
Editorial

Editorial: Steroid hormone receptors and cell cycle in breast cancer

Victoria T Fabris et al. Front Endocrinol (Lausanne). .
No abstract available

Keywords: breast cancer; cell cycle inhibitors; crosstalk; endocrine resistance; hormone receptors.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the editorial was written in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Comment on

  • Editorial on the Research Topic Steroid hormone receptors and cell cycle in breast cancer

References

    1. Patel HK, Bihani T. Selective estrogen receptor modulators (SERMs) and selective estrogen receptor degraders (SERDs) in cancer treatment. Pharmacol Ther (2018) 186:1–24. doi: 10.1016/j.pharmthera.2017.12.012 - DOI - PubMed
    1. Rojas PA, May M, Sequeira GR, Elia A, Alvarez M, Martínez P, et al. Progesterone receptor isoform ratio: A breast cancer prognostic and predictive factor for antiprogestin responsiveness. J Natl Cancer Inst (2017) 109(7):djw317. doi: 10.1093/jnci/djw317 - DOI - PMC - PubMed
    1. Roskoski R, Jr. Cyclin-dependent protein kinase inhibitors including palbociclib as anticancer drugs. Pharmacol Res (2016) 107:249–75. doi: 10.1016/j.phrs.2016.03.012 - DOI - PubMed
    1. Kowalczyk W, Waliszczak G, Jach R, Dulińska-Litewka J. Steroid receptors in breast cancer: Understanding of molecular function as a basis for effective therapy development. Cancers (Basel) (2021) 13(19):4779. doi: 10.3390/cancers13194779 - DOI - PMC - PubMed
    1. Jia M, Dahlman-Wright K, Gustafsson J-A. Estrogen receptor alpha and beta in health and disease. Best Pract Res Clin Endocrinol Metab (2015) 29(4):557–68. doi: 10.1016/j.beem.2015.04.008 - DOI - PubMed

Publication types